共 146 条
[1]
Cuchel M(2014)Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society Eur Heart J 35 2146-2157
[2]
Bruckert E(2013)Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society Eur Heart J 34 3478-3490
[3]
Ginsberg HN(2015)Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome Eur Heart J 36 560-565
[4]
Nordestgaard BG(1973)Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol Proc Natl Acad Sci U S A 70 2804-2808
[5]
Chapman MJ(2008)Hyperlipidemia in Saudi Arabia Saudi Med J 29 282-287
[6]
Humphries SE(2014)Hypercholesterolemia and its associated risk factors—Kingdom of Saudi Arabia, 2013 Ann Epidemiol 24 801-808
[7]
Sjouke B(2020)Improvement initiative in LDL-C management in Saudi Arabia: a call to action Int J Cardiol Heart Vasc 31 100667-2445
[8]
Kusters DM(2014)Cardiovascular risk factor burden in Africa and the Middle East: the Africa Middle East Cardiovascular Epidemiological (ACE) study PLoS One 9 e102830-64
[9]
Kindt I(2015)Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes Eur Heart J 36 2438-770
[10]
Goldstein JL(2020)The Gulf familial hypercholesterolemia registry (Gulf FH): design, rationale and preliminary results Curr Vasc Pharmacol 18 57-107